BBBP-GeoPEFT is proposed, a geometry-informed PEFT framework for pre-trained molecular GNNs that preserves pre-trained knowledge while incorporating permeability-relevant geometric information with a small trainable-parameter budget.
Abstract
Blood-brain barrier permeability (BBBP) prediction is a critical screening task in central nervous system drug discovery, where candidate molecules must be assessed for whether they can cross, or should be prevented from crossing, the blood-brain barrier. However, this task remains challenging because of limited, class-imbalanced datasets and sensitivity to molecular structure. Recent advances in deep learning have established graph neural networks (GNNs) as a powerful approach for molecular representation learning, while pre-trained molecular GNNs provide transferable knowledge for downstream tasks. However, full fine-tuning is often parameter-inefficient and prone to overfitting, whereas existing parameter-efficient fine-tuning (PEFT) methods mainly adapt node features or the two-dimensional covalent graph, limiting their ability to capture three-dimensional geometry and second-order interactions. To address these limitations, we propose BBBP-GeoPEFT, a geometry-informed PEFT framework for pre-trained molecular GNNs. BBBP-GeoPEFT constructs distance-based graphs at multiple cutoffs and their corresponding line graphs from molecular conformers to capture spatial atom and second-order edge interactions. Lightweight auxiliary geometric graph encoders generate cutoff-specific representations, which are incorporated into each pre-trained layer through node-wise cutoff attention and gated residual connections. This design preserves pre-trained knowledge while incorporating permeability-relevant geometric information with a small trainable-parameter budget. Experiments on a curated BBBP dataset show that BBBP-GeoPEFT achieves competitive performance compared with full fine-tuning and representative PEFT baselines. Under both random and scaffold splitting, BBBP-GeoPEFT achieves competitive or improved ROC-AUC and accuracy in most experiments while updating only 10.1% of the model parameters.
The challenge of early detection of Alzheimer's Disease (AD) and Mild Cognitive Impairment (MCI) is a neuroimaging challenge that has not been solved yet, as conventional deep learning architectures are not well suited to extract fine-grained localized features from the image while preserving the long-range structural...
S. Lokesh, P. Muthukumaraswamy, S. Priyan et al.· 2026 International Conferenc...· 0 citations
Accurate kidney and renal-tumor segmentation is challenging because lesion size, location, morphology, and boundary contrast vary substantially across abdominal CT scans. Most existing methods rely on a single form of local evidence and struggle to recover the boundaries of small lesions while maintaining global anat...
Si-Yuan Liang, Cheng-Chuan Xu, Chao Lu et al.· Frontiers in Artificial Inte...· 0 citations
Multi-dimensional lightweight modules can reconcile segmentation quality with strict computational budgets when adapting video-centric foundation models to 2D clinical data.
Xue-Jia Yuan, Zong-Jian Yang, Yu Guo et al.· IEEE transactions on bio-med...· 0 citations
A brain tumor is a life-threatening disease that carries a high mortality burden. It can be treated if detected in the early stages. Manual analysis by a radiologist using Magnetic Resonance Imaging (MRI) is effective but slow and subject to inter-observer variability. In order to automate it, various deep learning mod...
J. Sahoo, Surendra Kumar Nanda, Ganapati Panda et al.· Bioengineering· 0 citations
Retinal vessel segmentation in multi-domain deployment requires a source model to adapt to domains that differ in imaging conditions and annotation conventions. Conventional parameter-efficient fine-tuning reduces target-specific storage, but its highly restricted adaptation subspace can be insufficient for reconstruct...
Yong-Song Huang, T. Miyazaki, Kai Xu et al.· 0 citations
Brain age (BA) estimation from structural MRI is a promising biomarker for the early detection, monitoring, and risk stratification of neurodegenerative disorders, yet most existing approaches rely on black-box deep learning models that limit clinical interpretability. Prototype-based learning offers a promising altern...
Clara Lisazo, Adrià Casamitjana, A. Oliver et al.· Artificial Intelligence in M...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.